drugset
drugset / Trial / NCT01880528

Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer

NCT01880528 ↗

Phase 2 Completed 23 enrolled Mayo Clinic National Cancer Institute (NCI) · collab
RandomizedParallel-groupDouble-blindSupportive care

Summary

This pilot clinical trial studies lisinopril in reducing shortness of breath caused by radiation therapy in patients with lung cancer. Lisinopril may decrease the side effects caused by radiation therapy in patients with lung cancer.

Timeline

Start
2013-05-31
Primary completion
2013-06-05
Completion
2019-01-29

Drugs

EvaluationDrugModalityDoseRoute
Subject LISINOPRIL ANHYDROUS Small molecule — Oral

Indications

non-small cell lung carcinoma small cell lung carcinoma